Iterum Therapeutics (ITRM) Q2 2024 Earnings

13MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.93
-0.62
-0.31
-0

Details

Expected EPS
-0.725
Actual EPS
-0.38
Surprise EPS
0.35
Surprise Percent
+47.59%

Description

Iterum Therapeutics (ITRM) has reported earnings of -0.38 per share for Q2 2024.

0 Comments

Share your thoughts